Industry Partners

UC Davis Health expanded Taiwan partnerships to accelerate biomedical innovation, linking Aggie Square, universities and industry to drive research, commercialization and clinical translation in cell & gene therapy, cancer, medical devices, digital health and AI.

UC Davis, FLANN and partners launched the nine-month Scale-Up Program to help South Korean life-sciences startups enter the U.S. market via Aggie Square, offering clinical collaboration, U.S. market validation, commercialization support, investor access and strategic partnerships.

UC Davis strengthens its global life sciences ecosystem with strategic partnerships with FLANN Inc. and HM Venture Partners, aiming to attract international biotech startups to Aggie Square and accelerate the commercialization of groundbreaking healthcare innovations.